Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nithya Ramnath

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
Clinical Lung Cancer|July 16, 2010
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancerBryan J Schneider, Gregory P Kalemkerian, Nithya Ramnath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2011
Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosisGuoan Chen, Sinae Kim, Jeremy M G Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancerIbrahim S Aljada, Nithya Ramnath, Kathleen Donohue, et al.
Cost Effectiveness and Resource Allocation : C/E|September 5, 2024
Developing a systems-focused tool for modeling lung cancer screening resource needsAparna Reddy, Fumiya Abe-Nornes, Alison Haskell, et al.
Cancer|December 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitorsDaria Brinzevich, Virginia Falvello, Sadiq S Rehmani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumorsMarwan G Fakih, Patrick J Creaven, Nithya Ramnath, et al.
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancerThomas E Stinchcombe, Lydia Hodgson, James E Herndon, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 29, 2015
Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancerRishindra M Reddy, Vasudha Murlidhar, Lili Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2023
Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung CancerDonna M Edwards, Kamya Sankar, Aaren Alseri, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
Clinical Lung Cancer|July 16, 2010
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancerBryan J Schneider, Gregory P Kalemkerian, Nithya Ramnath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2011
Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosisGuoan Chen, Sinae Kim, Jeremy M G Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancerIbrahim S Aljada, Nithya Ramnath, Kathleen Donohue, et al.
Cost Effectiveness and Resource Allocation : C/E|September 5, 2024
Developing a systems-focused tool for modeling lung cancer screening resource needsAparna Reddy, Fumiya Abe-Nornes, Alison Haskell, et al.
Cancer|December 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitorsDaria Brinzevich, Virginia Falvello, Sadiq S Rehmani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumorsMarwan G Fakih, Patrick J Creaven, Nithya Ramnath, et al.
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancerThomas E Stinchcombe, Lydia Hodgson, James E Herndon, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 29, 2015
Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancerRishindra M Reddy, Vasudha Murlidhar, Lili Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2023
Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung CancerDonna M Edwards, Kamya Sankar, Aaren Alseri, et al.
Pageof 15